NO20061354L - Fremgangsmater og sammensetninger for oral administrering av prodroger av protonpumpe inhibitatorer - Google Patents
Fremgangsmater og sammensetninger for oral administrering av prodroger av protonpumpe inhibitatorerInfo
- Publication number
- NO20061354L NO20061354L NO20061354A NO20061354A NO20061354L NO 20061354 L NO20061354 L NO 20061354L NO 20061354 A NO20061354 A NO 20061354A NO 20061354 A NO20061354 A NO 20061354A NO 20061354 L NO20061354 L NO 20061354L
- Authority
- NO
- Norway
- Prior art keywords
- methods
- proton pump
- pump inhibitor
- compositions
- oral administration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Orale doseringsformer, fremgangsmåter for behandling av sykdommer eller ugunstige tilstander, og fremgangsmåter for hemming av magesyresekresjon relatert til prodroger av en protonpumpe inhibitor er angitt heri. Visse utførelsesformer angår membranpermeabiliteten av protonpumpe inhibitoren og/eller membranpermeabiliteten av prodrogen. Andre utførelsesformer angår prodroger omfattende en funksjonell syregruppe og en sulfonylgruppe. I andre utførelsesformer er prodrogen en karboksylsyre som omfatter en fenylsulfonylgruppe. Andre utførelsesformer angår pH av doseringsformer og doseringsformer omfattende salter av funksjonelle syregrupper.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US50835603P | 2003-10-03 | 2003-10-03 | |
US51388003P | 2003-10-22 | 2003-10-22 | |
PCT/US2004/032099 WO2005034951A1 (en) | 2003-10-03 | 2004-10-01 | Methods and compositions for the oral administration of prodrugs of proton pump inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20061354L true NO20061354L (no) | 2006-05-03 |
Family
ID=34437281
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20061354A NO20061354L (no) | 2003-10-03 | 2006-03-24 | Fremgangsmater og sammensetninger for oral administrering av prodroger av protonpumpe inhibitatorer |
Country Status (13)
Country | Link |
---|---|
US (1) | US20050075371A1 (no) |
EP (1) | EP1670467A1 (no) |
JP (1) | JP2007518700A (no) |
KR (1) | KR20060082082A (no) |
AR (1) | AR045857A1 (no) |
AU (1) | AU2004279378A1 (no) |
BR (1) | BRPI0415044A (no) |
CA (1) | CA2540977A1 (no) |
IL (1) | IL174265A0 (no) |
MX (1) | MXPA06003461A (no) |
NO (1) | NO20061354L (no) |
TW (1) | TW200522956A (no) |
WO (1) | WO2005034951A1 (no) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070060621A1 (en) * | 2004-02-18 | 2007-03-15 | Hughes Patrick M | Methods and compositions for the administration of prodrugs of proton pump inhibitors |
JP2007523164A (ja) * | 2004-02-18 | 2007-08-16 | アラーガン、インコーポレイテッド | プロトンポンプインヒビターに関連する化合物の静脈内投与のための方法および組成物 |
WO2007081871A1 (en) * | 2006-01-10 | 2007-07-19 | Allergan, Inc. | Therapeutic salt compositions of sulfonyl ester prodrugs of proton pump inhibitors and methods for their preparation |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE416649B (sv) * | 1974-05-16 | 1981-01-26 | Haessle Ab | Forfarande for framstellning av foreningar som paverkar magsyrasekretionen |
SE7804231L (sv) * | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
IL75400A (en) * | 1984-06-16 | 1988-10-31 | Byk Gulden Lomberg Chem Fab | Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same |
JPS6150978A (ja) * | 1984-08-16 | 1986-03-13 | Takeda Chem Ind Ltd | ピリジン誘導体およびその製造法 |
IL76839A (en) * | 1984-10-31 | 1988-08-31 | Byk Gulden Lomberg Chem Fab | Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same |
SE8505112D0 (sv) * | 1985-10-29 | 1985-10-29 | Haessle Ab | Novel pharmacological compounds |
FI90544C (fi) * | 1986-11-13 | 1994-02-25 | Eisai Co Ltd | Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi |
US4965269A (en) * | 1989-12-20 | 1990-10-23 | Ab Hassle | Therapeutically active chloro substituted benzimidazoles |
CA2083606C (en) * | 1990-06-20 | 2001-08-21 | Arne Elof Brandstrom | Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use |
SE9301830D0 (sv) * | 1993-05-28 | 1993-05-28 | Ab Astra | New compounds |
US5708017A (en) * | 1995-04-04 | 1998-01-13 | Merck & Co., Inc. | Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors |
SE510650C2 (sv) * | 1997-05-30 | 1999-06-14 | Astra Ab | Ny förening |
US6093734A (en) * | 1998-08-10 | 2000-07-25 | Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin | Prodrugs of proton pump inhibitors |
CN100396675C (zh) * | 1998-08-10 | 2008-06-25 | 加利福尼亚州大学董事会 | 质子泵抑制剂的前药 |
WO2004009583A2 (en) * | 2002-07-19 | 2004-01-29 | Garst Michael E | Benzimidazole derivatives and their use as prodrugs of proton pump inhibitor |
NZ544173A (en) * | 2003-07-15 | 2009-04-30 | Alevium Pharmaceuticals Inc | Process for preparing isomerically pure prodrugs of benzimidazole derivative proton pump inhibitors |
-
2004
- 2004-09-17 US US10/943,411 patent/US20050075371A1/en not_active Abandoned
- 2004-09-29 TW TW093129421A patent/TW200522956A/zh unknown
- 2004-10-01 AR ARP040103586A patent/AR045857A1/es not_active Application Discontinuation
- 2004-10-01 JP JP2006534083A patent/JP2007518700A/ja active Pending
- 2004-10-01 MX MXPA06003461A patent/MXPA06003461A/es not_active Application Discontinuation
- 2004-10-01 EP EP04785301A patent/EP1670467A1/en not_active Withdrawn
- 2004-10-01 WO PCT/US2004/032099 patent/WO2005034951A1/en active Application Filing
- 2004-10-01 BR BRPI0415044-9A patent/BRPI0415044A/pt not_active IP Right Cessation
- 2004-10-01 CA CA002540977A patent/CA2540977A1/en not_active Abandoned
- 2004-10-01 AU AU2004279378A patent/AU2004279378A1/en not_active Abandoned
- 2004-10-01 KR KR1020067006439A patent/KR20060082082A/ko not_active Application Discontinuation
-
2006
- 2006-03-12 IL IL174265A patent/IL174265A0/en unknown
- 2006-03-24 NO NO20061354A patent/NO20061354L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IL174265A0 (en) | 2006-08-01 |
AR045857A1 (es) | 2005-11-16 |
JP2007518700A (ja) | 2007-07-12 |
US20050075371A1 (en) | 2005-04-07 |
TW200522956A (en) | 2005-07-16 |
EP1670467A1 (en) | 2006-06-21 |
AU2004279378A1 (en) | 2005-04-21 |
WO2005034951A1 (en) | 2005-04-21 |
MXPA06003461A (es) | 2006-06-05 |
CA2540977A1 (en) | 2005-04-21 |
KR20060082082A (ko) | 2006-07-14 |
BRPI0415044A (pt) | 2006-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2338311A1 (en) | Prodrugs of the pyridyl methyl sulfinyl benzimidazoles | |
NO20055370L (no) | Alfa-substituert karboksylsyre som PPAR modulatorer | |
IS2696B (is) | Setin 2-amínótetralín fyrir meðhöndlunina á geðdeyfð | |
NO20062905L (no) | Nye hydroksaminsyreestere og farmasoytisk anvendelse derav | |
NO20060114L (no) | Naftylenderivater som cytokrom P450-inhibitorer | |
NO20061432L (no) | N3 alkylerte benzimidazolederivater som MEK-inhibitorer | |
CY1112831T1 (el) | Παραγωγα αζαβιρηενυlαμινοβενζοιc acid σαν παραγοντες καταστολης dhodh | |
NO20092033L (no) | Nye forbindelser | |
NO20073831L (no) | Medikamenter for behandling eller forebygging av fibrotiske sykdommer | |
BRPI0418245B8 (pt) | composto derivado de nitróxi de prostaglandina, processo para preparar dito composto, composição farmacêutica compreendendo dito composto e usos destes | |
ATE341550T1 (de) | Quinolinyl-pyrrolopyrazole | |
NO20050801L (no) | Prodrug av protonpumpe inhibitorer | |
NO20050667L (no) | N-substituerte-1H-indol-5-propionsyreforbindelser som PPAR agonister nyttige for behandling av diabetes | |
NO20083836L (no) | N-hydroksyakrylamidforbindelser | |
NO20081942L (no) | Karbamoylbenzotriazolderivater som inhibitorer av lipaser og fosfolipaser | |
PE20050822A1 (es) | Derivados de florfenicol con mejor solubilidad en agua | |
BRPI0111591B8 (pt) | composto, composição farmacêutica, e, usos de um composto | |
NO20083708L (no) | 4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer | |
AU2002215932A1 (en) | Nitroderivatives as drugs for diseases having an inflammatory basis | |
EP1334971A4 (en) | BENZIMIDAZOLE COMPOUNDS, METHOD FOR THE PRODUCTION AND USE THEREOF | |
NO20061354L (no) | Fremgangsmater og sammensetninger for oral administrering av prodroger av protonpumpe inhibitatorer | |
NO20063859L (no) | Cykloalkylsubstituerte 7-amino-4-kinolon-3-karboksylsyrederivater, fremgangsmate for fremstilling derav og anvendelse derav som medikamenter | |
NO20054418L (no) | Substituert benzoylureidopyridylpiperidin- og -pyrrolidinkarboksylsyrederivater, deres fremstilling og anvendelse | |
NO20070250L (no) | S-Tenatoprazol-natriummonohydratsalt og dennes anvendelse i form av en protonpumpe-inhibitor | |
NO20084625L (no) | Renininhibitorer for behandlingen av hypertensjon |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |